Sandoz Ancozan 50 mg

Ancozan is a pharmaceutical drug containing losartan potassium, primarily used to treat hypertension (high blood pressure). It is marketed under the Sandoz brand, which is one of the world's leading names in generic and biosimilar medicines.

Sandoz was originally founded in Switzerland in 1886 and became a major part of Novartis through a merger in 1996. However, in late 2023, Sandoz was successfully spun off as an independent, publicly traded company. Its manufacturing network is global, with significant production facilities across Europe (such as Austria, Germany, and Slovenia) and Asia, ensuring supply for various international markets including Denmark.

The brand is currently owned by Sandoz Group AG, headquartered in Basel, Switzerland. Following its separation from Novartis, it continues to operate as a standalone global leader in the generic pharmaceuticals sector.